DEF 14A: Sabra Health Care REIT Announces 2024 Annual Meeting of Stockholders

Sabra Health Care REIT's 2024 Annual Meeting of Stockholders will address director elections, auditor ratification, and executive compensation.

Summary

• Sabra Health Care REIT will hold its 2024 Annual Meeting of Stockholders on June 13, 2024, at its headquarters in Tustin, California.
• Stockholders of record as of April 16, 2024, are entitled to vote.
• The meeting will address the election of eight directors, ratification of PricewaterhouseCoopers LLP as the independent accounting firm, and an advisory vote on executive compensation.
• The Board of Directors recommends voting for all director nominees, the ratification of PwC, and the approval of executive compensation.
• Proxy materials were first sent or made available to stockholders on or about April 26, 2024.
• The company's focus on internal growth, including enhancing its portfolio and strengthening its balance sheet, has resulted in Sabra entering 2024 stronger and more diverse than at any other time in the Company's history.
• As of December 31, 2023, Sabra had approximately $946.9 million in liquidity.

Sentiment

Score: 7

Explanation: The document is generally positive, outlining the company's strategic direction and governance practices. The focus on long-term value creation and alignment with shareholder interests contributes to a favorable sentiment.

Positives

• The Board of Directors is actively seeking qualified women and individuals from minority groups to include in the pool from which new Board members or director nominees are selected.
• Since March 2019, Sabra has appointed four new directors with a diverse range of skills, expertise and backgrounds, all of whom are diverse by gender or race and/or ethnicity.
• The company's focus on internal growth, including enhancing its portfolio and strengthening its balance sheet, has resulted in Sabra entering 2024 stronger and more diverse than at any other time in the Company's history.
• As of December 31, 2023, Sabra had approximately $946.9 million in liquidity, consisting of unrestricted cash and cash equivalents of $41.3 million and available borrowings of $905.6 million under our revolving credit facility.

Future Outlook

Sabra is focused on fortifying its balance sheet, refining its portfolio, and supporting its tenants and operators.

Management Comments

• Michael L. Costa, Chief Financial Officer, stated that Sabra remains focused on the fundamentals: fortifying its balance sheet, refining its portfolio and supporting its tenants and operators.
• Richard K. Matros, Chief Executive Officer, stated that Sabra's ESG principles are intrinsically tied to its objective to drive shareholder value and that they are focused on how effectively they can integrate them into their business strategy in ways that are self-sustaining and accretive.

Industry Context

The document provides insight into Sabra's strategic focus on healthcare-related real estate, aligning with broader industry trends in senior housing and skilled nursing facilities.

Comparison to Industry Standards

• The document references several peer companies, including Acadia Realty Trust, CareTrust REIT, and Omega Healthcare Investors, indicating a focus on maintaining competitive compensation and governance practices within the REIT sector.
• The document references the Nareit Health Care Property Sector Total Return Index as a benchmark for TSR performance.

Stakeholder Impact

• The document outlines potential impacts on shareholders through voting on key proposals.
• The document outlines potential impacts on employees through compensation and benefits programs.
• The document outlines potential impacts on tenants and operators through the company's strategic focus.

Next Steps

• Stockholders are urged to submit their proxy votes before the specified deadlines.
• The company will announce preliminary voting results at the Annual Meeting and disclose final results in a Form 8-K filing.

Key Dates

Keywords

Annual Meeting, Stockholders, Board of Directors, Proxy Statement, Executive Compensation, Director Election, Auditor Ratification, Corporate Governance, Sabra Health Care REIT, REIT